| Authors: |
Thampi N; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain; Red Española de Terápias Avanzadas (TERAV). Instituto de Salud Carlos III, Barcelona, Spain; Spanish National Cancer Network (CIBERONC). Instituto de Salud Carlos III, Barcelona, Spain., Calvo C; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain; Red Española de Terápias Avanzadas (TERAV). Instituto de Salud Carlos III, Barcelona, Spain; Spanish National Cancer Network (CIBERONC). Instituto de Salud Carlos III, Barcelona, Spain., Rodríguez-Cortez V; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain; Red Española de Terápias Avanzadas (TERAV). Instituto de Salud Carlos III, Barcelona, Spain; Spanish National Cancer Network (CIBERONC). Instituto de Salud Carlos III, Barcelona, Spain., Martínez-Moreno A; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain; Red Española de Terápias Avanzadas (TERAV). Instituto de Salud Carlos III, Barcelona, Spain; Spanish National Cancer Network (CIBERONC). Instituto de Salud Carlos III, Barcelona, Spain., Roca-Ho H; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain; Red Española de Terápias Avanzadas (TERAV). Instituto de Salud Carlos III, Barcelona, Spain; Spanish National Cancer Network (CIBERONC). Instituto de Salud Carlos III, Barcelona, Spain., Vinyoles M; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain; Red Española de Terápias Avanzadas (TERAV). Instituto de Salud Carlos III, Barcelona, Spain; Spanish National Cancer Network (CIBERONC). Instituto de Salud Carlos III, Barcelona, Spain., Bueno C; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain; Red Española de Terápias Avanzadas (TERAV). Instituto de Salud Carlos III, Barcelona, Spain; Spanish National Cancer Network (CIBERONC). Instituto de Salud Carlos III, Barcelona, Spain., Espinosa-Aroca L; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain; Red Española de Terápias Avanzadas (TERAV). Instituto de Salud Carlos III, Barcelona, Spain; Spanish National Cancer Network (CIBERONC). Instituto de Salud Carlos III, Barcelona, Spain., Pablo-Fontecha V; August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and CIBEREHD, Barcelona, Spain., Camps J; August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and CIBEREHD, Barcelona, Spain; Cell Biology and Medical Genetics Unit, Department of Cell Biology, Physiology and Immunology, School of Medicine, Autonomous University of Barcelona, Barcelona, Spain., de la Fuente-González A; Departament of Biochemistry and Molecular Biology, Instituto Universitario de Oncología (IUOPA), University of Oviedo, Oviedo, Spain., Puente XS; Spanish National Cancer Network (CIBERONC). Instituto de Salud Carlos III, Barcelona, Spain; Departament of Biochemistry and Molecular Biology, Instituto Universitario de Oncología (IUOPA), University of Oviedo, Oviedo, Spain., Solé F; Josep Carreras Leukemia Research Institute, Catalan Institute of Oncology (ICO), Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain., Foijer F; European Research Institute for the Biology of Ageing (ERIBA), University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Menéndez P; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain; Red Española de Terápias Avanzadas (TERAV). Instituto de Salud Carlos III, Barcelona, Spain; Spanish National Cancer Network (CIBERONC). Instituto de Salud Carlos III, Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain; Department of Biomedicine, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; Pediatric Cancer Centre Barcelona-Institut de Recerca Sant Joan de Deu (PCCB-SJD), Barcelona, Spain. Electronic address: pmenendez@carrerasresearch.org., Molina O; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain; Red Española de Terápias Avanzadas (TERAV). Instituto de Salud Carlos III, Barcelona, Spain; Spanish National Cancer Network (CIBERONC). Instituto de Salud Carlos III, Barcelona, Spain; Genetics Section, Department of Physiological Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. Electronic address: omolina@ub.edu. |
